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Sepsis-induced myocardial dysfunction is a major contributor to the poor outcomes
of septic shock. As an add-on with conventional sepsis management for over
15 years, the effect of Xuebijing injection (XBJ) on the sepsis-induced myocardial
dysfunction was not well understood. The material basis of Xuebijing injection (XBJ)
in managing infections and infection-related complications remains to be deﬁned.
A murine cecal ligation and puncture (CLP) model and cardiomyocytes in vitro culture
were adopted to study the inﬂuence of XBJ on infection-induced cardiac dysfunction.
XBJ signiﬁcantly improved the survival of septic-mice and rescued cardiac dysfunction
in vivo. RNA-seq revealed XBJ attenuated the expression of proinﬂammatory
cytokines and related signalings in the heart which was further conﬁrmed on the
mRNA and protein levels. Xuebijing also protected cardiomyocytes from LPS-induced
mitochondrial calcium ion overload and reduced the LPS-induced ROS production in
cardiomyocytes. The therapeutic effect of XBJ was mediated by the combination of
paeoniﬂorin and hydroxysafﬂor yellow A (HSYA) (C0127-2). C0127-2 improved the
survival of septic mice, protected their cardiac function and cardiomyocytes while
balancing gene expression in cytokine-storm-related signalings, such as TNF-α and
NF-κB. In summary, Paeoniﬂorin and HSYA are key active compounds in XBJ for
managing sepsis, protecting cardiac function, and controlling inﬂammation in the
cardiac tissue partially by limiting the production of IL-6, IL-1β, and CXCL2.
Keywords: Xuebijing injection, septic shock, sepsis-induced myocardial dysfunction, paeoniﬂorin (Pae),
hydroxysafﬂor yellow A (HSYA), cytokine storm, CXCL2/MIP-2

HIGHLIGHTS
• Xuebijing injection protected cardiac function during systemic infection partially by downregulating the expression of pro-inﬂammatory cytokines and related pathways in the cardiac
tissue.
• Paeoniﬂorin and hydroxysafﬂor yellow A in XBJ rescued mice from septic shock.
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• Paeoniﬂorin and hydroxysafﬂor yellow A in XBJ protected
cardiac function in septic mice partially by inhibiting the
expression of pro-inﬂammatory cytokines/chemokines and
related pathways in the cardiac tissue.

and renders organ protections during systemic infection (Liu et al.,
2014a; Chen et al., 2018; Shang et al., 2019). Paeoniﬂorin claims
the highest concentration and hydroxysafﬂor yellow A claims the
2nd highest concentration among all detectable compounds in
Xuebijing injection (Cheng et al., 2016; Shang et al., 2019; Li
et al., 2020a). A series of studies indicated these two compounds
are promising Xuebijing constituents of therapeutic importance
(Cao et al., 2011; Zhai and Guo, 2016b; Cheng et al., 2016; Zou et al.,
2018; Shang et al., 2019). Paeoniﬂorin improved survival and
cardiac function in LPS-treated rodents (Cao et al., 2011; Zhai
and Guo, 2016b; Liu et al., 2016). HSYA improved ischaemiainduced cardiac haemodynamics by stimulating nucleolinmediated angiogenesis (Zou et al., 2018).
Though XBJ has been used to treat sepsis as an add-on for over
one and a half decades, several key questions remain to be
addressed: 1. What’s the inﬂuence of XBJ on sepsis-induced
cardiac dysfunction? 2. What are the mechanisms of XBJ in
managing sepsis-induced cardiac dysfunction? 3. Which
compounds in XBJ play major roles in managing septic shock?
4. Which compounds in XBJ play a major role in managing sepsisinduced cardiac dysfunction? In this study, we try to address these
questions by evaluating the impact of XBJ and its key compounds
(paeoniﬂorin and hydroxysafﬂor yellow A) on cardiac function in a
clinical relevant shock model (Barth et al., 2006) and investigating
the molecular mechanism.

INTRODUCTION
The mortality rate in septic shock generally exceeds 40% (Beesley
et al., 2018). Sepsis-induced cardiomyopathy (SIC), a frequent incident
in sepsis, contributes to the poor outcomes of septic shock (Ehrman
et al., 2018; Martin et al., 2019). Circulating proinﬂammatory
cytokines act directly on cardiomyocytes and vasculatures to
compromise myocardial performance (Ehrman et al., 2018). It is
believed that TNF-α, IL-1β, and IL-6 are major contributors to SIC
(Pathan et al., 2004; Liu et al., 2017; Martin et al., 2019).
Results of clinical trials suggested that beta-adrenergic agonists
and levosimendan were not effective in improving outcomes in
sepsis patients (Gordon et al., 2016; Walley, 2018). Medications
improving cardiovascular function and targeting proinﬂammatory
cytokines showed therapeutic potentials to manage sepsis and
sepsis-induced myocardial dysfunction (Li et al., 2007; Walley,
2018). However, targeting TLR4 signaling with Eritoran did not
improve survival in sepsis patients (Opal et al., 2013; Martin et al.,
2019). Murine monoclonal anti-TNF-α improved ventricular
function in patients with septic shock. But it did not improve
patient survival (Vincent et al., 1992; Abraham et al., 1998).
Approved to treat sepsis and septic shock as an add-on in China
since 2004, Xuebijing injection signiﬁcantly improved the survival
of severe pneumonia patients in a large-scale clinical trial (Cheng
et al., 2016; Zhang et al., 2018; Song et al., 2019). Showing promising
clinical effect in managing severe COVID-19 and saving thousands
of lives in China, it was recently approved to treat moderate and
severe CVOID-19 in China (Fan et al., 2020). Activating circulation
and remove stasis, XBJ maintains the balance of the immune system
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MATERIALS AND METHODS
Chemicals and Reagents
Xuebijing injection (catalog number: z20040033, batch number:
1905061) was manufactured by Tianjin Chase Sun Pharmaceutical
Co., Ltd (Tianjin, China). Paeoniﬂorin (CAS #:23180-57-6),
Hydroxysafﬂor yellow A (CAS #: 78281-02-4), Ferulic acid (CAS
# 537- 98-4), and protocatechuic aldehyde (CAS #: 139-85-5) were
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purchased from Shanghai Yuanye Biotechnology Co., Ltd.
(Shanghai, China). Mouse NT-proBNP ELISA (Cat#: ZC-3781296T) kit, DCFH-DA (Cat#:CA1410-100T), RIPA tissue/cell lysate
(Cat#: R0020), SDS-PAGE gel kit, and Rainbow 245 Spectrum
Marker (Cat#:PR 1920), Mouse IL-6 ELISA kit (Cat#:ZC-3798896T), Mouse IL-1β ELISA kit (Cat#:ZC-37974-96T), and EasySee
Western Blot Kit (Lot#:O30807) were purchased from Solarbio
(Beijing, China). The primary antibody of rabbit anti-CXCL2
(bs-1162R) was purchased from Bioss Inc., (Beijing, China) and
GAPDH, 1:4,000 (14C10) was from Cell Signaling Technology
(Beverly, MA, United States). The secondary antibody Goat antiRabbit IgG (1:4,000) (ZB-2301) was purchased from ZS bio (Beijing,
China). 2, 2, 2-Tribromoalcohol (Cat#:T48402) and Bacterial
lipopolysaccharide (Cat#: L2880-10 MG) were purchased from
Sigma Aldrich (St. Louis, MO, United States). Rhod2-AM (Cat#:
zy0129) and Anti-GRP78 (BiP) antibody (ab21685) were purchased
from Abcam (Cambridge, MA, United States).

#: 78281-02-4), ferulic acid (0.02 mg/ml, CAS # 537-98-4), and
protocatechuic aldehyde (0.01 mg/ml, CAS #: 139-85-5) were
dissolved in PBS before the tail-vein injection. Drug treatment
was started three days before the cecal ligation and puncture,
Xuebijing (9 ml/kg), C0127 (9 ml/kg), C0127-2 (9 ml/kg) were
administered twice/day by tail-vein injections to the
corresponding groups. Two hrs after CLP, XBJ (9 ml/kg) and
C0127s (9 ml/kg) were administered every 12 h by tail-vein
injection. Saline was administered to sham and CLP group by
every 12 h by tail-vein injection. Mice were feed and supplied
with water daily.

RNA Samples Collection
Twenty-four hours after CLP surgery, the hearts of mice (including
normal mice, CLP group, XBJ treatment group, C0127 treatment
group, C0127-2 treatment group) were collected. The intracavity
blood was washed with normal saline, and the hearts were
immediately placed into liquid nitrogen. The hearts were later
used for high-throughput sequencing on an Illumina sequencing
platform (4 in each group). RNA was extracted from cardiac tissue
using standard extraction method as described (Lyu et al., 2018a)
and was reverse transcribed using NEB Next Ultra RNA library
preparation kit for Illumina .

Animals
This study was carried out following the recommendations of the
Guide for the Care and Use of Laboratory Animals (NIH Publication
No. 85-23, revised 1996, United States) and the recommendations in
the Guidance for the Care and Use of Laboratory Animals issued by
the Ministry of Science and Technology of China. All experiments
were approved by the Experimental Animal Ethics Committee of
Tianjin University of Traditional Chinese Medicine (Tianjin, China)
and performed in accordance with its guidelines (license number:
TCM-LAE-20170017). Male ICR mice, 6-week-old, were purchased
from Beijing Vital River Laboratory Animal Technology Co., Ltd.
(Beijing, China, Certiﬁcate no.: SCXK Jing 2012-0001). They were
kept under controlled temperature (22 ± 2°C) and relative humidity
(40% ± 5%) conditions, fed commercial rat food and puriﬁed water,
and had a 12-h light/dark cycle.

®

™

RNA-Seq
RNA Quantiﬁcation and Quality Testing
RNA degradation and contamination was monitored on 1% agarose
gels. RNA purity was checked using the NanoPhotometer
spectrophotometer (IMPLEN, CA, United States). RNA integrity
was assessed using the RNA Nano 6000 Assay Kit of the Bioanalyzer
2100 system (Agilent Technologies, CA, United States).

®

Library Preparation for Transcriptome Sequencing
A total amount of 1 μg RNA per mouse was used as input material
for the RNA preparations. Sequencing libraries were generated
using NEB Next UltraTMRNA Library Prep Kit for Illumina
(NEB, United States) following manufacturer’s recommendations
and index codes were added to attribute sequences to each
sample. Brieﬂy, mRNA was puriﬁed from total RNA using
poly-T oligo-attached magnetic beads. Fragmentation was
carried out using divalent cations under elevated temperature
in NEB Next First Strand Synthesis Reaction Buffer (5X). Firststrand cDNA was synthesized using random hexamer primer and
M-MuLV Reverse transcriptase (RNase H-). Second strand
cDNA synthesis was subsequently performed using DNA
Polymerase I and RNase H. Remaining overhangs were
converted into blunt ends via exonuclease/polymerase
activities. After adenylation of 3′ ends of DNA fragments,
NEB Next Adaptors with hairpin loop structure were ligated
to prepare for hybridization. In order to select cDNA fragments
of preferentially 250∼300 bp in length, the library fragments were
puriﬁed with the AMPureXP system (Beckman Coulter, Beverly,
United States). Then 3 μl USER Enzyme (NEB, United States) was
used with size-selected, adaptor-ligated cDNA at 37°C for 15 min
followed by 5 min at 95°C before PCR. Then PCR was performed
with Phusion High-Fidelity DNA polymerase, Universal PCR
primers and Index (X) Primer. At last, PCR products were

Cecal Ligation and Puncture

®

As described previously (Rittirsch et al., 2009; Chen et al., 2018),
the abdomen of an anesthetized mouse was depilated, and an
incision of less than 1 cm was cut with scissors to expose the
cecum which was ligated with a 2–0 line 1/3 from the ileocecal
valve. An 18G-needle was used to perforate the cecum (one hole),
and then a small amount of feces a little feces was squeezed out.
After the operation, the cecum was returned to the original
position, the wound was sutured with a 4–0 suture, and the
mouse was kept on an electric blanket after the operation.

Drug Administration
The animals were randomly divided into ﬁve groups, sham group,
CLP group, CLP + Xuebijing group, CLP + C0127 group, and CLP +
C0127-2 group. C0127 was deﬁned as the combination of
paeoniﬂorin (2 mg/ml, CAS #:23180-57-6), hydroxysafﬂor yellow
A (0.5 mg/ml, CAS #: 78281-02-4), ferulic acid (0.02 mg/ml, CAS #
537-98-4), and protocatechuic aldehyde (0.01 mg/ml, CAS #: 13985-5) at the indicated concentrations (Shang et al., 2019). C0127-2
was deﬁned as the combination of paeoniﬂorin (2 mg/ml, CAS
#:23180-57-6) and hydroxysafﬂor yellow A (0.5 mg/ml, CAS #:
78281-02-4) at the indicated concentration. Paeoniﬂorin (2 mg/
ml, CAS #:23180-57-6), hydroxysafﬂor yellow A (0.5 mg/ml, CAS
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GO and KEGG Enrichment Analysis of Differentially
Expressed Genes
Gene Ontology (GO) enrichment analysis of differentially expressed
genes were implemented using the clusterProﬁler R package, in
which gene length bias were corrected. GO terms with corrected p
value less than 0.05 were considered signiﬁcantly enriched by
differential expressed genes. KEGG is a database resource for
understanding high-level functions and utilities of the biological
system, such as the cell, the organism and the ecosystem, from
molecular-level information, especially large-scale molecular
datasets generated by genome sequencing and other highthrough put experimental technologies (http://www.genome.jp/
kegg/). We used clusterProﬁler R package to test the statistical
enrichment of differential expression genes in KEGG pathways.

puriﬁed (AMPure XP system) and library quality was assessed on
the Agilent Bioanalyzer 2100 system.

Clustering and Sequencing
The clustering of the index-coded samples was performed on a
cBot Cluster Generation System using TruSeq PE Cluster Kit v3cBot-HS (Illumina) according to the manufacturer’s instructions.
After cluster generation, the library preparations were sequenced
on an Illumina Novaseq platform and 150 bp paired-end reads
were generated.

Data Analysis
Quality Control
Raw data (raw reads) of FastQ format were ﬁrstly processed
through in-house Perl scripts. In this step, clean data (clean
reads) were obtained by removing reads containing adapter,
reads containing ploy-N and low quality reads from raw data.
At the same time, Q20, Q30 and GC content the clean data
were calculated. All the downstream analyses were based on
the clean data with high quality.

Elisa
Twenty-four hours after CLP, blood was collected and was left at room
temperature for 30 min. The clot was removed by centrifuging at
1,500 g for 10 min at 4°C in a centrifuge. The IL-1β, IL-6, and NTproBNP were detected using ELISA kits by an automatic biochemical
analyzer (Multiskan MK3; Thermo Fisher Scientiﬁc, Waltham, MA,
United States), according to the manufacturer’s instructions as
previously described (Lyu et al., 2018a; Chen et al., 2018).
The concentrations of IL-1β and IL-6 in the heart tissue were
determined following the manufacturers’ protocol. In brief, the
hearts of mice were harvested and rinsed with normal saline 24 h
after the CLP procedure. 10ul high-efﬁciency RIPA lysis buffer for
every 1 mg of heart tissue and 10 ul PMSF protease inhibitor for
every 1 ml lysis buffer were added to the heart tissue. Later, the
tissues was homogenized with an Ultrasonic Tissue Homogenizer
(Ningbo Scientz Biotechnology, Ningbo, China) on ice and the tissue
supernatant was centrifuged at 13000 g for 5 min. The levels of IL-6
and IL-1β in the cardiac tissue were measured following the
manufacturer’s instructions.

Reads Mapping to the Reference Genome
Reference genome and gene model annotation ﬁles were
downloaded from genome website directly. Index of the
reference genome was built using Hisat2 v2.0.5 and paired-end
clean reads were aligned to the reference genome using Hisat2
v2.0.5. Hisat2 was selected as the mapping tool since it can
generate a database of splice junctions based on the gene
model annotation ﬁle and thus a better mapping result than
other non-splice mapping tools.
Quantiﬁcation of Gene Expression Levels
Feature Counts v1.5.0-p3 was used to count the reads
numbers mapped to each gene. And then FPKM of each
gene was calculated based on the length of the gene and reads
count mapped to this gene. FPKM, expected number of
Fragments Per Kilobase of transcript sequence per Million
base pairs sequenced, was used to assess the effect of
sequencing depth and gene length for the reads count. It is
currently the most commonly used method for estimating
gene expression levels.

Transthoracic Echocardiography in Mice
Cardiac left ventricular function and coronary blood ﬂow were
assessed non-invasively at 24 h after CLP using an ultrahigh
resolution small animal ultrasound Vevo 2,100 Imaging System
(Visual Sonics, Toronto, ON, Canada) equipped with a 30 MHz
transducer (Respress and Wehrens, 2010). As described previously
(Respress and Wehrens, 2010), mice were anesthetized (2%
isoﬂurane mixed with 0.5 L/min of 100% O2) before imaging.
The animals were removed from the induction chamber and the
hair on the chest was removed with a depilatory cream. The
anesthetized mice were lying on a heating pad with embedded
ECG leads to maintain body temperature. Nose cone connected to
the anesthesia system was used to maintain a stable sedation level
throughout the process (1.0–1.5% isoﬂurane mixed with 0.5 L/min
of 100% O2). The level of anesthesia was adjusted to achieve a target
heart rate (bpm) of 450 ± 50 beats per minute. Four claws were
attached to the ECG electrode with electrode gel. The probe was
gently placed on the mouse’s chest to locate the left ventricle
during the testing. Three cardiac cycles were measured for each
mouse and the average value was taken. All data were analyzed
after the experiment using the software provided with the
ultrasound system.

Differential Expression Analysis
For DESeq2 with biological replicates, differential expression
analysis of two conditions/groups (two biological replicates
per condition) was performed using DESeq2 R package
(1.16.1). DESeq2 provides statistical routines for
determining differential expression in digital gene
expression data using a model based on the negative
binomial distribution. The resulting p-values were adjusted
using the Benjamini and Hochberg’s approach for controlling
the false discovery rate. Genes with an adjusted p-value <0.05
found by DESeq2 were assigned as differentially expressed.
The p values were adjusted using the Benjamini and
Hochberg method. A corrected p-value of 0.05 and
absolute fold change of two were set as the threshold for
signiﬁcantly differential expression.

Frontiers in Pharmacology | www.frontiersin.org

4

April 2021 | Volume 11 | Article 614024

Wang et al.

Xuebijing Attenuates SIC

TABLE 1 | The primer sequences for real-time PCR experiments.
Gene
GAPDH
TLR4
HMGB1
POSTN
GRP78
IL-6
IL-1β
BNP
BIRC3
CEBPB
PTGS2
CXCL5
CD14
FOS
CXCL2
CXCL12
ICAM1
IL1A

Forward Primer (59-39)

Reverse primer (59-39)

TGGTGAAGCAGGCATCTGAG
ATGGCATGGCTTACACCACC
GGCGAGCATCCTGGCTTATC
CCTGCCCTTATATGCTCTGCT
GTTTGCTGAGGAAGACAAAAAGCTC
TAGTCCTTCCTACCCCAATTTCC
GCAACTGTTCCTGAACTCAACT
CTGAAGGTGCTGTCCCAGATG
ACGCAGCAATCGTGCATTTTG
ACACGTGTAACTGTCAGCCG
TTCAACACACTCTATCACTGGC
TCCAGCTCGCCATTCATGC
CTCTGTCCTTAAAGCGGCTTAC
GGTGAAGACCGTGTCAGGAGGCAG
CCAACCACCAGGCTACAGG
CGCCAAGG-TCGTCGCCG
GTGATGCTCAGGTATCCATCCA
CAGTTCTGCCATTGACCATC

TGCTGTTGAAGTCGCAGGAG
GAGGCCAATTTTGTCTCCACA
GGCTGCTTGTCATCTGCTG
AAACATGGTCAATAGGCATCACT
CACTTCCATAGAGTTTGCTGATAATTG
TTGGTCCTTAGCCACTCCTTC
ATCTTTTGGGGTCCGTCAACT
GACGGATCCGATCCGGTC
CCTATAACGAGGTCACTGACGG
GCTCGAAACGGAAAAGGTTC
AGAAGCGTTTGCGGTACTCAT
TTGCGGCTATGACTGAGGAAG
GTTGCGGAGGTTCAAGATGTT
GCCATCTTATTCCGTTCCCTTCGG
GCGTCACACTCAAGCTCTG
TTGGCTCTGGCGATGTGGC
CACAGTTCTCAAAGCACAGCG
TCTCACTGAAACTCAGCCGT

Cell Cultures

The primer sequences for real-time PCR were presented in
Table 1.

H9C2 cells were trypsinized, washed, and then seeded in a 96well black plate at a density of 10,000 cells per well in DMEM
medium containing 10% fetal bovine serum. The cells were
cultured in an incubator with 37 °C, 5% CO2 for 24 h. After
stimulation with LPS (1ug/ml), Xuebijing (1:20/1:100), C0127
(1:20/1:100), and C0127-2 (1:20/1:100) were added to the cell
culture. DCFH-DA (Jiang et al., 2018) and RHOD2 (Joseph
et al., 2017) probes were loaded 12 h later. After incubating at
37°C for 30 min and washing 3 times with PBS, images were
taken and analyzed with a PerkinElmer high-content imaging
system as described (Lyu et al., 2018b).

Hematoxylin and Eosin Staining
Hematoxylin and eosin (H & E) staining was described previously
(Xiao et al., 2019). Brieﬂy, heart tissue was collected 24 h after CLP
and was ﬁxed at room temperature in 4% formalin for at least 48 h,
dehydrated, and parafﬁn-embedded. Then the tissue was sectioned
in 5-μm thickness, then, stained with H and E at room temperature
for 1-2 min. The pictures were taken with an Olympus microscope.

Western Blot
Western Blot was conducted as described with modiﬁcations (Zhai
and Guo, 2016a). Firstly, the total protein of heart tissue was
extracted with a commercial available Protein Extraction Kit
Solarbio (Beijing, China). The protein concentration was
determined using the Bio-Rad DC Protein Determination Kit,
with bovine serum albumin (BSA) as the standard. The proteins
were separated by SDS-PAGE on 12% separation gels, transferred to
hydrophobic polyvinylidene (PVDF) membranes, and blocked with
TBST (Tris-buffered saline with Tween-20) containing 5% non-fat
dry milk. Primary antibodies of CXCL2 (1:1,000 dilution), GAPDH
(1:4,000 dilution) were incubated at 4°C overnight. Then,
membranes were washed three times with TBST and incubated
with secondary antibodies for 2 h at room temperature. The
immunoblots were developed using the ECL kit.

Real-Time PCR
Real-time PCR experiments were conducted as described (Xiao
et al., 2019). Twenty-four hours after surgery, the mouse hearts
were taken out and stored in liquid nitrogen, and then liquid
nitrogen was added to pre-cool the mortar. One ml of lysate was
added to each tissue sample, and the tissue was ground. The
homogenate was separated and the supernatant was removed.
RNA was isolated with chloroform, precipitated with isopropyl
alcohol, washed with 75% ethanol and was dissolved with
ultrapure water. The RNA concentration, purity and integrity
were separately measured using Qubit RNA Assay Kit in Qubit
2.0 Fluorometer (Life Technologies, CA, United States), the
NanoPhotometer spectrophotometer. Immediately after RNA
extraction, total RNA was reverse transcribed into cDNA
following the instructions of the Transcriptor First Strand
cDNA Synthesis Kit (Roche, Mannheim, Germany). Later realtime PCR was performed in 25ul reaction system. Samples were
denatured at 95°C for 30s, annealed at 60°C for 30s, and extended
at 72°C for 40s.The relative mRNA level was determined using
the comparative CT method and was normalized to the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The primers were synthesized by Sangon Company
(Shanghai, China).

Frontiers in Pharmacology | www.frontiersin.org

Statistical Analysis
All tests were performed using GraphPad Prism seven software
(GraphPad Software, Inc., La Jolla,CA, United States). All
experiments were expressed as the mean ± SEM or mean ± SD.
Statistical analysis was carried out using Student’s two-tailed t-test for
comparison between two groups and One-way analysis of variance
(ANOVA) followed by Dunnett’s test the data involved three or more
groups. p < 0.05 was considered as statistically signiﬁcant.
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RESULTS

studies (Chen et al., 2018; Villa et al., 1995). XBJ treatment drastically
altered the gene expression proﬁle in CLP mice (Figure 5A,
Supplementary Figure S3B). It impacted the expression of 1839
genes in CLP mice for over two-fold (Figures 5B,D). GO analysis
revealed infection and inﬂammation-related gene functions were
among the top 10 biological processes among the 1839 genes
inﬂuenced by XBJ, such as response to LPS, response to
molecules of bacteria origin, and leukocyte migration
(Supplementary Figures S6A,B). KEGG analysis of the XBJimpacted genes revealed that multiple signaling pathways,
including Cytokine-cytokine receptor binding, IL17 signaling, NFκB, and TNF-α signaling, were related to inﬂammation and cytokine
storm (Supplementary Figures 6C,D), conﬁrming the results of
previous studies that XBJ reduced pro-inﬂammatory cytokine
production in the septic mice (Villa et al., 1995; Chen et al., 2018).

XBJ Protected the Cardiac Function in a
Septic Shock Model
In vivo and in vitro experiments were designed to determine the
inﬂuence of XBJ on the cardiac function in septic shock (Figure 1). A
septic shock model was established using the cecal ligation and
puncture (CLP) procedure. All CLP mice died in 48 h after the
procedure and all mice in the sham group survived, indicating the
model was established successfully (Supplementary Figure S2B).
Cardiac function was measured 24 h after CLP to evaluate the
impact of XBJ. CLP signiﬁcantly compromised cardiac function
by reducing ejection fraction (EF%), fractional shortening (FS%), left
ventricular posterior wall diastole (LVPWd), and left ventricular
posterior wall systole (LVPWs) while increasing left ventricular
internal diameter diastole (LVIDd) and left ventricular internal
diameter systole (LVIDs), respectively, when compared with the
saline-treated sham group. XBJ signiﬁcantly improved EF, FS,
LVPWd, LVPWs, LVIDd, and LVIDs in septic mice (Figure 2).

XBJ Down-Regulated the NF-κB Signaling
in the Cardiac Tissue of Septic Mice
As an early signaling activated in sepsis, NF-κB activates
the transcription of a series of proinﬂammatory cytokines to
activate cytokine storm in septic shock, including TNF-α, IL-1β,
and IL-12 (Hotchkiss et al., 2016). Several groups reported that XBJ
regulates NF-κB signaling which activates a series of proinﬂammatory cytokines, including TNF-α, IL-6, and IL-1 (Jiang
et al., 2013; Chen et al., 2018). Our RNA-seq assay revealed that XBJ
regulated NF-κB signaling spanning from the receptor, intracellular
effectors, transcription factor, and downstream targets (Figure 6A).
The expression of at least six genes in NF-κB signaling was
conﬁrmed by Real-time PCR assay, including CD14, CXCL2,
and Ptgs2 (Figures 6B–G).

XBJ Protected Cardiac Tissue Upon
Systemic Infection and Protected
Cardiomyocytes From LPS-Induced
Mitochondria Ca2+ Overload and
ROS Production
H & E staining was conducted to determine the morphology of
Cardiac tissue in different groups of mice. Consistent with previous
observations by dos Santos et al. (dos Santos et al., 2010), no signiﬁcant
differences in necrosis or ﬁbrosis between CLP and sham mice were
detected. However, increased edema associated with some
myoﬁbrillary loss was observed in CLP mice (Supplementary
Figures S5A,B). XBJ treatments reduced edema and myoﬁbrillary
loss in CLP mice (Supplementary Figure S5C). Elisa assay revealed
that XBJ signiﬁcantly reduced N-terminal (NT)-pro hormone BNP
(NT-ProBNP) in the peripheral blood (Figure 3A). Consistently, the
mRNA expression of B-type natriuretic peptide (BNP), a marker of
heart failure (McLean et al., 2008) in the heart tissue was also decreased
in the XBJ treated group (Figure 3B). To determine whether XBJ can
protect cardiac tissue on the cellular level, in vitro assays were
conducted on H9C2 cardiomyocytes upon LPS stimulation. XBJ
not only reversed LPS-induced Ca2+ overload in the mitochondria
(Figures 4A,C) but also reduced ROS production (Figures 4B,D).

XBJ Down-Regulated TNF-α Signaling and
the Expression of Proinﬂammatory
Cytokines and Cytokine Receptors in the
Cardiac Tissue of Septic Mice
Expressed early in the pathogenesis of sepsis, TNF-α is a potential
therapeutic target in sepsis (Hotchkiss et al., 2016; Huang et al.,
2019). XBJ reduced TNF-α production in patients and pre-clinical
models (Chen et al., 2018; He et al., 2018). RNA-seq analysis did not
reveal a signiﬁcant difference of TNF-α expression between CLP and
XBJ treated group in the cardiac tissue on RNA level 24 h after CLP
(data not shown). However, the expression of multiple TNF-α
downstream targets was signiﬁcantly reduced in XBJ treated
septic mice, compared with the CLP group (Figure 7A). The
expression of more than six genes in TNF-α signaling was
conﬁrmed with real-time PCR, including intracellular protein
Birc3 (cIAP2), transcription factor C/EPBβ, TNF-α downstream
targets ICAM1, CXCL2, CXCL5, FOS, and PTGS2 (COX2) (Figures
7B–G). Some of them were molecules in NF-κB signaling (ICAM1,
PTGS2 (COX2) (Aronoff, 2012), and Birc3) (Figure 6). Besides, XBJ
impacted the expression of more than 50 Cytokine-cytokine receptor
interaction molecules in the cardiac tissue of septic mice, including
key pro-inﬂammatory cytokines causing tissue damages, such as IL6, IL-1α and IL-1β (Figures 8A–D). The down-regulation of IL-6,
IL-1α, and IL-1β by XBJ was further conﬁrmed by Real-time PCR

XBJ Down-Regulated the Expression of
Infection and Inﬂammation-Related
Signaling in the Cardiac Tissue of
Septic Mice
To identify the potential down-stream effectors of XBJ in the cardiac
tissue, RNA sequencing was conducted to determine the gene
expression proﬁles of the cardiac tissue in the control and XBJ
treated groups. GO and KEGG analysis of the RNA-seq results
revealed overwhelming up-regulation of infection and inﬂammationrelated pathways in the CLP group compared to the sham group,
including NF-κB, TNF-α, and cytokine-cytokine receptor signaling
(data not shown). This is consistent with the results of previous
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FIGURE 1 | Scheme of the experimental design. In vivo and in vitro assays were used to determine the impacts of XBJ, C0127, and C0127-2 on infection-induced
cardiac dysfunction and potential mechanisms.

(Figures 8E–G). Elisa assay conﬁrmed that XBJ inhibited IL-6 and
IL-1β in the serum and cardiac tissue (Figures 9A,B,D,E). Western
Blot analysis validated that XBJ inhibited the expression of CXCL2 in
the cardiac tissue (Figures 9C,F).

(Figure 3A). They also reduced the mRNA expression of
B-type natriuretic peptide (BNP) (McLean et al., 2008) in the
cardiac tissue of septic mice (Figure 3B). In addition, the
expression of TLR4, its downstream effector HMGB1,
periostin, and GRP78 (an effector of ER stress (Shang et al.,
2019)) were moderately decreased in C0127s treated groups
(Figures 3C–F). H&E staining showed that C0127s reduced
edema and myoﬁbrillary loss in CLP mice. There were no
obvious differences between XBJ and C0127s treated groups
(Supplementary Figures S5C–E).
On the cellular level, C0127s reversed Ca2+ overload in the
mitochondria (Figures 4A,C) and reduced ROS production
(Figures 4B,D) in LPS-stimulated H9C2 cells, suggesting the active
compounds in XBJ protect cellular functions of cardiomyocytes.

C0127s Represented XBJ Function in
Improving the Survival and Protecting the
Cardiac Function in a Septic Shock Model
So far, the potential material base of XBJ in sepsis management
and infection-related cardiac protection was not clear. Since a
combination of four compounds in XBJ (C0127) prevented
Candida-induced sepsis and kidney failure (Shang et al., 2019),
we hypothesized that XBJ attenuates infection-induced cardiac
dysfunction and C0127 plays a major role in managing septic
shock and infection-induced cardiac depression. Like XBJ, C0127
and C0127-2 rescued about 35% of septic mice from acute death.
There was no signiﬁcant difference among the treatment groups
(Supplementary Figure S2B).

Active Ingredients in XBJ Down-Regulated
Gene Expression in Infection and
Inﬂammation-Related Signaling in the
Cardiac Tissue of Septic Mice
We conducted an RNA sequencing to determine the impacts of
C0127s on the expression proﬁle of the cardiac tissue in septic mice.
The gene expression patterns were consistent in each group
(Supplementary Figure S3B). Similar to XBJ intervention,
C0127s shifted the gene expression proﬁle of the CLP group
(Figure 5A, Supplementary Figure S3B). C0127s treatments
triggered more changes in the gene expression proﬁle of CLP
mice, comparing to the XBJ treated group (Figure 5B). Notably,
952 genes were differentially regulated by XBJ and C0127s for >2
fold, revealing similar expression trends as the sham group
(Supplementary Figure S3A). We further analyzed these genes
using GO and KEGG databases as references.
GO analysis revealed infection and inﬂammation-related gene
functions were among the top 10 biological processes in the 952

C0127s Protected the Cardiac Tissue
During Systemic Infection Partially by
Preventing LPS Induced Injuries in
Cardiomyocytes
Echocardiography was used to address the question of whether
active ingredients in XBJ render cardiac protection in septic mice.
C0127s showed similar effects as XBJ in most parameters,
including LVIDd, LVIDs, LVPWs, LVEF %, and LVFS
(Figure 2). Nonetheless, C0127s did not signiﬁcantly alter the
LVPWd (Figure 2D). C0127-2 treatment did not signiﬁcantly
impact the LVPWs (Figure 2E).
Consistently, C0127s reduced N-terminal (NT)-pro
hormone BNP (NT-ProBNP) in the peripheral blood
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FIGURE 2 | XBJ and key compounds in XBJ protected cardiac function of septic mice. (A) Representative images of left ventricular echocardiography. Cardiac
performance was determined by echocardiography in different groups as indicated. (B) Left ventricularejection fraction (LVEF) %, (C) Left ventricular fractional shortening
(LVFS) % were measured in M-mode, (D) LV posterior wall diastole (LVPWd), (E) LV posterior wall systole (LVPWs), (F) Left ventricular internal dimensions at diastole
(LVIDd), (G) Left ventricular internal diameter systole (LVIDs), Results were presented as mean ± SEM (n  7–10/group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs.
Sham group, *p < 0.05, **p < 0.01 vs. CLP group.
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FIGURE 3 | XBJ and C0127s intervention protected hearts in septic mice. (A) N-terminal (NT)-pro hormone BNP (NT-ProBNP) levels in different groups
were determined by Elisa assay. n  4/group. mRNA expression of B-type natriuretic peptide (BNP) (B), TLR4 (C), HMGB1(D), Periostin (E), and GRP78 (F)
in heart tissue of different groups were determined by real-time PCR in heart tissue of different groups. n  4–5/group. Results were presented as mean ±
SEM (n  4-5/group). # p < 0.05, ## p < 0.01, ### p < 0.001 vs. Sham group, *p < 0.05, **p < 0.01, ***p < 0.001 vs. CLP group.

genes, such as response to LPS, response to molecules of bacteria
origin, and leukocyte migration (Figures 10A,B). Interestingly, the
top three signaling pathways impacted by C0127s among the 952
genes, such as IL17 signaling, Cytokine-cytokine receptor binding,
and TNF-A signaling pathway, were also the top pathways
impacted by XBJ (Figures 10C,D). Like XBJ, C0127s
signiﬁcantly down-regulated gene expression in the infection and
proinﬂammatory signaling (Figure 10E). PPAR signaling was upregulated by XBJ and C0127s (Figure 10F).

the expression of the same genes in TNF-α signaling in the
cardiac tissue (Figure 7A). The expression of 24 genes in TNFα signaling and 38 Cytokine-cytokine receptor interaction
molecules which were inﬂuenced by XBJ, were also similarly
impacted by C0127s in the cardiac tissue in septic mice
(Figures 7A, 8A, and Supplementary Tables). The impacts
of C0127s on at least six genes in TNF-α signaling were
conﬁrmed with real-time PCR, including intracellular protein
Birc3 (cIAP2), transcription factor C/EPBβ, TNF-α downstream
targets ICAM1, CXCL2, CXCL5, FOS, and PTGS2 (COX2) (Figures
7B–E, 6). Some of them were also regulated by XBJ and C0127s in
NF-κB signaling (ICAM1, PTGS2 (COX2) (Aronoff 2012), and
Birc3). Similar to XBJ, C0127s signiﬁcantly down-regulated the
expression of IL-6, IL-1α, and IL-1β in the cardiac tissue of
septic mice (Figures 8B–D). These results were also conﬁrmed
with real-time PCR (Figures 8E–G).

Active Ingredients in XBJ Down-Regulated
the Expression of NF-kB Target Genes in the
Cardiac Tissue of Septic Mice
Like XBJ, C0127s also regulated NF-κB signaling spanning from
the receptor, intracellular effectors, transcription factors, to the
downstream targets (Figures 6A,B, and Supplementary
Tables). Twenty genes in NF-κB signaling which were
impacted by XBJ, were also down-regulated by C0127s in the
cardiac tissue of the septic mice (Figure 6A). The inﬂuences of
C0127s on the expression of at least six genes in the NF-κB
signaling were conﬁrmed by the Real-time PCR assay, including
CD14, CXCL2, and Ptgs2 (Figures 6B–G).

C0127s Inhibited the Septic Shock-Induced
Myocardial Production of Inﬂammatory
Cytokines/Chemokines
To further evaluate the impacts of C0127s on the inﬂammatory
cytokine/chemokine production, we determine the inﬂammatory
cytokines/chemokines in the serum and cardiac tissue of CLP
mice using ELISA and Western blot. CLP induced a drastic
increase of IL-6 and IL-1β in the peripheral blood and the
cardiac tissue 24 h after the CLP procedure. C0127s
pretreatment signiﬁcantly inhibited the IL-1β and IL-6
production (Figures 9A,B,D,E). Western blot further
conﬁrmed that C0127s inhibited CXCL2 production in the
cardiac tissue (Figures 9C,F). Overall, attenuating cytokine
storm by XBJ and its key ingredients may play a major role in
protecting cardiac function in septic shock.

Active Ingredients in XBJ Down-Regulated
TNF-α Signaling and the Expression of
Pro-inﬂammatory Cytokine and Cytokine
Receptors in the Cardiac Tissue of Septic
Mice
Interestingly, C0127s not only mimicked the effect of XBJ on
sepsis progression and cardiac protection, they also regulated
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FIGURE 4 | XBJ and C0127s protected mitochondria and reduced ROS production in cardiomyocytes. H9C2 cells were treated with LPS at the presence and
absence of XBJ, C0127, and C0127-2 at different concentrations. Rhode2 Florescent probe was used determine Ca2+ level in mitochondria and FITC probe was used to
detect ROS production in a high-content imaging system. (A) Representative images of Ca2+ level in mitochondria in different treatments. (B) Representative images of ROS
level in different treatments. (C) Quantiﬁcation of Ca2+ levels in different treatments. (D) Quantiﬁcation of ROS production in different treatments. Results were presented
as mean ± SEM. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. control, *p < 0.05, **p < 0.01, ***p < 0.001 vs. LPS treated cells. Experiments were repeated for 3 times.

DISCUSSION

work showed C0127, a 4-compound formula, mimicked the
effect of XBJ in preventing systemic Candida infection (Shang
et al., 2019), indicating high-concentration compounds in XBJ
may execute its major functions in vivo. Paeoniﬂorin (Pae) and
Hydroxysafﬂor yellow A (HSYA) are the two compounds with
the highest and 2nd highest concentrations in XBJ (Li et al.,
2020a) (The chemical structures of compounds in XBJ
(including Pae and HSYA) were shown in Supplementary
Figure S1). They are key indicators for the quality control of
this injection (Zhang et al., 2018; Shang et al., 2019). How these
two compounds affect septic shock and infection-induced
cardiac injuries/dysfunction was not well-understood. XBJ
and C0127s signiﬁcantly improved survival in a murine
septic shock model. However, there was no signiﬁcant
difference between the intervention groups, indicating Pae
and HSYA are major active compounds in XBJ to manage
septic shock.

In this study, we focused on the inﬂuence of XBJ on infectioninduced cardiac dysfunction and the potential molecular
mechanism of its effects. We found XBJ and C0127s
improved survival and cardiac function after systemic
infection. RNA-seq analysis revealed that C0127s exerted
similar functions as XBJ in controlling the cytokine storm
and inﬂammation-related signaling pathways, including NFκB and TNF-α signaling. Real-time PCR experiments conﬁrmed
the results of RNA sequencing on the mRNA level. XBJ and
C0127s protected the cardiac tissue after the septic shock by
normalizing the expression of pro-inﬂammatory cytokines (IL-6
and IL-1β), chemokines (CXCL2, CXCL5, and CXCL12), and
molecules in TNF-α and NF-κB signaling. XBJ and C0127s also
protected cardiac function on the cellular level by reducing LPSinduced ROS production and calcium overload in mitochondria
of cardiomyocytes. These ﬁndings partially explained the
protective effects of XBJ in septic shock and severe COVID19 patients.

C0127s Improved the Cardiac Function of
Septic Mice
Limited studies were conducted on cardiac dysfunction in
systemic infection. Dos Santos et al. observed the downregulation of PPAR signaling in the cardiac tissue of a murine
CLP model (dos Santos et al., 2010). Consistently, our studies
revealed XBJ and C0127s signiﬁcantly up-regulated PPAR
signaling which is critical for normal cardiac function
(Supplementary Figures 4A,B).

C0127s Improved the Survival of
Septic Mice

XBJ contains compounds derived from ﬁve different Chinese
medicinal herbs (Cheng et al., 2016; Chen et al., 2018; Shang
et al., 2019). It is not clear which compounds in XBJ played
major roles in managing sepsis and septic shock. Our previous
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FIGURE 5 | XBJ and C0127s normalized the gene expression proﬁle in the cardiac tissue of septic mice. 24 hs after CLP, mice were euthanized and heart tissue
were harvested and subjected to RNA-seq analysis. (A) Heat map of the gene expression proﬁles in different groups. (B) Differential gene counts between different
groups. (C–F) Overall distribution of differentially expressed genes (fold change >2 and p-Value <0.05) was reﬂected by the volcanic map. The X-axis represents the
changes of gene expression in different samples and Y-axis represents the statistical signiﬁcance of the difference in the gene expression. The up-regulated genes
were in red and down-regulated genes in green. (C) Differentially expressed genes of CLP vs. Sham group; (D) Differentially expressed genes of CLP vs. XBJ group; (E)
Differentially expressed genes of CLP vs. C0127 group; (F) Differentially expressed genes of CLP vs. C0127-2 group. n  4/Group except XBJ and C0127 group (n  3).
p value < 0.05, |Log2FoldChange| > 1.
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FIGURE 6 | XBJ and C0127s impacted the gene expression of NF-kB signaling pathway in the cardiac tissue of septic mice. (A) Heat map of the gene expression
inﬂuenced by XBJ, C0127, and C0127-2 in NF-κB signaling. (B–G) Real-time PCR experiments were conducted to conﬁrm the results of RNA-seq assay. (B) CD14;
(C) TNFAIP3; (D) PTGS2; (E) CXCL2; (F) CXCL12; (G) ICAM1. All Real-time PCR experiments were conducted twice. n  4/group. Results were presented as mean ±
SEM (n  4-5/group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs. Sham group, *p < 0.05, **p < 0.01, ***p < 0.001 vs. CLP group.

From septic shock to COVID-19, systemic infections compromise
cardiac function (dos Santos et al., 2010; Zheng et al., 2020). Patients
with cardiovascular conditions are more vulnerable to the assaults of
systemic bacterial infection (Zhu et al., 2020). Protecting the
cardiovascular function of these high-risk patients may save tens of

thousands of lives. Our IPA network pharmacology analysis predicted
that XBJ, a formula of Chinese medicine activating circulation and
removing stasis, may improve cardiovascular function. Some
publications also provided evidence for the role of XBJ in
regulating cardiovascular function (Zhai and Guo, 2016a).

FIGURE 7 | XBJ and C0127s down-regulated TNF-α signaling in the cardiac tissue of septic mice on mRNA level. (A) Heat map of the gene expression inﬂuenced
by XBJ and C0127s in TNF-α signaling in the RNA-seq assay. (B–E) Real-time PCR experiments were conducted to conﬁrm the results of RNA-seq assay. B. Birc3; C.
C/EBPβ; D. FOS; E. CXCL5. n  4/group. All Real-time PCR experiments were conducted twice. Results were presented as mean ± SEM (n  4/group). #p < 0.05, ##p <
0.01, ###p < 0.001 vs. Sham group, *p < 0.05, **p < 0.01, ***p < 0.001 vs. CLP group.
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FIGURE 8 | XBJ and C0127s down-regulated the mRNA expression of pro-inﬂammatory cytokines and cytokine receptors in the cardiac tissue after systemic
infection. (A) Heat map of the gene expression inﬂuenced by XBJ, C0127, and C0127-2 in Cytokine-cytokine receptor interaction in the RNA-seq assay. (B–D) The
expression of pro-inﬂammatory cytokines, IL-6, IL-1α, and IL-1β were detected in the cardiac tissue of different groups of mice. B. IL-6; C. IL-1α; D. IL-1β. (E–G) The
expression of pro-inﬂammatory cytokines in the cardiac tissue of different groups of mice was determined by Real-time PCR. E. IL-6; F. IL-1α; G. IL-1β. n  4-5/
group. Results were presented as mean ± SEM (n  4-5/group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs. Sham group, *p < 0.05, **p < 0.01, ***p < 0.001 vs. CLP group.

In a well-established septic shock-induced myocardial
dysfunction model, we observed similar phenotypes as
previously described (dos Santos et al., 2010). Overall,

C0127s showed similar effects as XBJ in restoring cardiac
functions in the septic mice (Figure 2). No signiﬁcant
differences were observed between C0127 and C0127-2

FIGURE 9 | XBJ and C0127s down-regulated the protein expression of pro-inﬂammatory cytokines/chemokines in the septic mice. (A,B) The serum levels of (A)
IL-1β and (B) IL-6 were measured by ELISA. Each bar was represented as mean ± SEM (n  5); (D,E) The levels of (D) IL-1β and (E) IL-6 in heart tissues were measured
by ELISA. Each bar was represented as mean ± SEM (n  5); (C,F) The expression of CXCL2 in the heart tissue of different groups was determined by western blot. Each
bar was represented as mean ± SEM (n  5/group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs. Sham group, *p < 0.05, **p < 0.01, ***p < 0.001 vs. CLP group.
Experiments were repeated for three times.
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FIGURE 10 | XBJ and C0127s regulated infection and inﬂammation related signaling in septic shock. (A,B) GO analysis of the top 30 functions impacted by XBJ
and C0127s. BP, biological process, CC, cellular component, MF, molecular function. Padj: P value adjusted. (C,D) The KEGG 676 analysis of top 20 pathways of the
952 genes impacted by XBJ and C0127s for >2 fold. The pathways/functions were ranked from left to right by −log (P value adjusted). (E,F) KEGG analysis of the top
signaling pathways up-regulated (E) or down-regulated (F) by XBJ and C0127s were presented.
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XBJ and C0127s Directly or Indirectly
Attenuate Cytokine Storm to Protect
Cardiac Function and Improve Survival in
Septic Shock

group, suggesting paeoniﬂorin and HSYA are the core
compounds in XBJ for cardiac protection.
Two previous studies suggested paeoniﬂorin rendered
cardiac protection in LPS-induced endotoxemia models
(Zhai and Guo, 2016b; Liu et al., 2016). Liu et al. found
12 mg/kg paeoniﬂorin once/day reduced plasma CK-MB (a
biomarker of severe heart damage) to normal level 72 h after
the LPS administration (5 mg/kg) in a rat model (Liu et al.,
2016). Zhai and Guo revealed that paeoniﬂorin reduced proinﬂammatory cytokine production in the cardiac tissue of a
LPS-induced cardiac-dysfunction mouse model (Zhai and
Guo, 2016b). Treating mice with paeoniﬂorin 15 mg/kg/
day for 3 days before LPS injection (10 mg/kg) improved
cardiac function in endotoxemic mice and reduced LPSinduced Leukocyte inﬁltration in the cardiac tissue. It
reduced LPS-induced cytokine production on mRNA level
(in the cardiac tissue) and protein level (in the serum),
including IL-6, TNF-α, IL-12, IL-1β, and IFNγ (Zhai and
Guo, 2016b). These results indicated that paeoniﬂorin may
play an important role in XBJ and C0127s to reduce the
cytokine expression in the cardiac tissue of the septic mice in
our study.
HSYA, which promotes angiogenesis, was known for its antithrombosis effect. It is used to treat stroke and ischaemic
cardiovascular diseases in China. HSYA (240 mg/kg/day) rescued
CD4 T cell apoptosis in a mouse CLP model. HSYA (240 mg/kg/
day) also protected mice from LPS-induced lung injury (Liu et al.,
2014b; Wang et al., 2017). Another study discovered that HSYA
(25 mg/kg/day) stimulated angiogenesis to improve cardiac function
in a murine ischaemic model (Zou et al., 2018). This effect was
mediated by nucleolin, a DNA-binding molecule that regulates
angiogenesis. Huber et al. found HSYA can enter cardiac
myocytes to reduce anoxia/reoxygenation-induced damage by
interacting with the mitochondrial permeability transition pore
in vitro (Huber et al., 2018).
So far, it is not clear whether HSYA can improve survival and
cardiac function in CLP mice. Overall, our and other groups’
results suggested paeoniﬂorin and HSYA may synergistically
improve cardiac function during systemic infection by
reducing cytokine/chemokine production.
Biochemical and molecular analysis in vivo and in vitro
further conﬁrmed the results of echocardiography. C0127s not
only reduced NT-pro-BNP on the protein level but also inhibited
other drivers of cardiac dysfunction, such as IL-6, IL-1β and
CXCL2 expression on mRNA and protein level (Figures 3A,B,
8, 9) (McLean et al., 2008; Zhu et al., 2020). They also reduced LPS
induced ROS production and Calcium overload in the
mitochondria of cardiomyocytes (Figure 4).
The increased GRP78 expression in the cardiac tissue of
CLP mice was a response to the CLP- induced acute cardiac
stress (Figure 3F). This result echoed ﬁndings by a recent
study (Bi et al., 2018). Bi et al. revealed that overexpressing
GRP78 protected myocytes from I/R-induced cell death by
activating AKT signaling. It is likely that the decreased
expression of GRP78 after XBJ and C0127s treatment
indicated the reduced ER stress an improved cardiac
function in CLP mice.
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To explore the molecular mechanism of XBJ on infectioninduced cardiac dysfunction, we conducted RNA–seq assay in
different groups of mice to determine the impact of XBJ and
C0127s on the gene expression proﬁle of septic hearts. GO and
KEGG analysis revealed that XBJ and C0127s regulate infection
and inﬂammation related signalings in septic mice (Figure 10).
The most pronounced change in the gene expression proﬁle of
XBJ-treated CLP mice was the pan-reduction of gene expression
related to cytokine storms during infection (Figure 10 and
Supplementary Figures S6C,D). Not only pro-inﬂammatory
cytokines such as IL-1α, IL-1β, and IL-6 but also the cytokine
receptors, cellular mediators, downstream transcription factors,
and target genes were down-regulated by the treatments (Figures
6, 7, 8). Consistently, C0127s also down-regulated the same
groups of pro-inﬂammatory cytokines and receptors (Figures
6, 7, 8), indicating paeoniﬂorin and HSYA are the core
compounds in XBJ to regulate the local expression of
inﬂammation-related signaling in the cardiac tissue of septic
mice. CD40-NF-κB signaling pathways is a representative
signaling pathway signiﬁcantly down-regulated by XBJ and
C0127s. CD154, a marker of cardiac ischemia and the ligand
of CD40, was often elevated in septic patients (McLean et al.,
2008). Both CD154 and CD40 are potential therapeutic targets of
cardiovascular disease (Bosmans et al., 2020). In our study, XBJ
and C0127s signiﬁcantly reduced the expression of CD40. In
addition, the expression of NF-κB p65 subunit (RELA) was also
reduced upon XBJ and C0127s treatments (Figure 6A). This
result was consistent with a previous report that XBJ reduced NFκB protein expression in the lung (He et al., 2018).
Additionally, XBJ and C0127s down-regulated the mRNA and
protein expression of NF-κB targets, IL-6 and IL-1β, in the
cardiac tissue. Given that IL-6 is a marker of cardiac ischemia
(McLean et al., 2008), XBJ and C0127s may improve circulation
in the cardiac function of septic mice. These results suggested
Pae and HSYA are core compounds in XBJ to regulate proinﬂammation cytokine production in the cardiac tissue.

The Inﬂuence of XBJ and C0127s on CXCL2
CLP stimulated the expression of a series of chemokines in the
cardiac tissue, including CXCL1, CXCL2, and CXCL5. XBJ and
C0127s signiﬁcantly down-regulated the expression of these
chemokines (Figures 7A, 8A, 9A). Real-time PCR conﬁrmed
these effects on CXCL2, CXCL5, and CXCL12 in the cardiac
tissue (Figures 8E, 9C,F). Western blot analysis further validated
that XBJ and C0127s inhibited CXCL2 protein expression (Figures
4E,F). Consistent with our results, Li et al., found XBJ downregulated CXCL2 expression in a methicillin-resistant
Staphylococcus aureus (MRSA) infection model (Li et al., 2020a).
CXCL2, which is also known as Macrophage Inﬂammatory
Protein 2 (MIP-2) and GRO2, is a small cytokine that is expressed
in a spectrum of tissues and organs including the heart (https://
www.ncbi.nlm.nih.gov/gene/20310). CXCL1 (GRO1) shares 90%
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of sequences with CXCL2. Both CXCL1 and CXCL2 can be
secreted by monocytes and neutrophils at the site of
inﬂammation. They function through the chemokine receptor
CXCR2 to act as chemotactic agents for leukocytes and
hematopoietic cells (Sawant et al., 2020).
Two studies revealed that CXCL2 polymorphism is related to
the severity of sepsis in patients, suggesting CXCL2 playing an
important role in the development of severe sepsis (Flores et al.,
2006; Villar et al., 2007). IL-17, NF-κB, and IL-1β can stimulate
CXCL2 expression in pathological conditions (Guo et al., 2020).
CXCL2 is believed to be a critical therapeutic target in myocardial
infarctions (MI) (Guo et al., 2020). A high level of CXCL2
worsens MI by stimulating neutrophil-mediated cardiac
injuries. Interventions that down-regulate CXCL2 relieved
neutrophil-mediated cardiac injuries (Montecucco et al., 2010;
Montecucco et al., 2013; Mylonas et al., 2017). Our results
suggested XBJ improves cardiac function partially by reducing
CXCL1 and CXCL2 production to limit the neutrophil-mediated
cardiac injury. Interestingly, C0127s also down-regulated the
mRNA and protein expression of CXCL2 (Figures 6A,E,
9C,F). How XBJ and C0127s regulate CXCL2 signaling in
different cell types remains to be determined.
The balance of CXCL12 (SDF-1) and CXCL2 chemokines favors
neutrophil retention in the BM in steady-state conditions (Eash et al.,
2010; Day and Link, 2012). Under stress situations such as infections,
G-CSF induces massive neutrophil egress into the circulation. G-CSF
inhibits SDF-1 expression in the BM. It also causes cleavage of
surface CXCR4 (a CXCL12 receptor) on neutrophils, disrupting
SDF-1/CXCR4 signaling, which leads to their mobilization (Day and
Link, 2012). Guan et al. found that combining CTCE (a peptide
analogue of CXCL12) and antibiotics improves survival and
neutrophil recruitment in a murine sepsis model (Guan et al.,
2014). However, Liehn et al.’s results raised a concern about the
expression of endogenous CXCL12 on cardiovascular function in a
myocardial infarction (MI) model (Liehn et al., 2011). Increased
expression of CXCL12 in the cardiac tissue after XBJ and C0127s
treatments may indicate a balanced neutrophil mobilization or
improved clearance of infection (Figure 6F). More studies need
to be conducted to explain this phenomenon in the cardiac tissue.

Deceased COVID-19 patients had signiﬁcantly higher IL-6
expression than the survivors of COVID-19 (Ruan et al., 2020;
Zhou et al., 2020). As a promising therapeutic target of severe
COVID-19, IL-6 was downregulated by XBJ in clinical studies
and pre-clinical studies.
Approved to treat COVID-19 in China, XBJ was effective in
managing moderate and severe COVID-19. The results of this study
partially revealed the working mechanism of XBJ in protecting
cardiac function and controlling cytokine storm upon systemic
infection. Our results suggested that XBJ might be a safe option
for protecting cardiac function, controlling infection-induced
cytokine storm, and preventing bacteria superinfection in
severe COVID-19 patients.

Future Directions
Clearing of dying/dead cells and extracellular matrix is a key
function of cardiac resident macrophages (Li et al., 2021).
Enhancing macrophage efferocytosis can activate the antiinﬂammatory program and reduce the damages caused by
apoptotic neutrophils (Greenlee-Wacker, 2016). Limited
studies have been conducted on the impact of cardiac
resident
macrophages
on
sepsis-induced
cardiac
dysfunction and the inﬂuence of XBJ on cardiac resident
macrophages. Liu et al. found XBJ (5 mg/mL) enhanced the
survival and the expression of M2 markers in LPS-stimulated
mouse peritoneal macrophages (Liu et al., 2015). It is
important to understand the inﬂuence of XBJ and C0127s
on the bone marrow derived macrophages and cardiac
resident macrophages in sepsis. Several important
questions remain to be answered. It will be important to
understand the inﬂuences of bone marrow-derived
macrophages and cardiac resident macrophages on the
cardiac function in septic shock models. It is not clear
how XBJ and C0127s inﬂuence the function of
macrophages in the cardiac tissue of the CLP mice.
Whether they inﬂuence the inﬁltration of bone marrow
derived macrophages in the CLP model is not known either.
GDF3 and Sectm1a have been shown to inﬂuence cardiac
function of septic mice and are potential therapeutic targets of
sepsis-induced cardiac dysfunction (Li et al., 2020b; Mu et al.,
2020; Wang et al., 2020). XBJ and C0127s may impact cardiac
function of septic mice by inﬂuence these potential therapeutic
targets. How XBJ and C0127s regulate these signaling remains to
be unveiled.

The Implication of This Study for COVID-19
Management
COVID-19 patients having cardiac complications are suffering
the second-highest mortality rate in the global pandemic.
Cardiovascular complications occurred in up to 16% of critically ill
COVID-19 patients (Li et al., 2020a; Zhu et al., 2020). Myocardial
injury is a leading cause of severe illness and mortality in SARS-CoV-2
infection (Tersalvi et al., 2020; Zheng et al., 2020). About 5% of
COVID-19 patients undergo septic shock and multiple organ failure
(Russell et al., 2020; Zhu et al., 2020). Stunningly, 70% of patients who
died of COVID-19 had septic shock (Hantoushzadeh and
Norooznezhad, 2020). Sharing multiple traits with septic shock,
severe COVID-19 was deﬁned as viral sepsis (Shankar-Hari et al.,
2016; Li et al., 2020a).
High levels of IL-6 and IL-1β drive the cytokine storm in
severe COVID-19 patients, causing organ injuries and MODS.
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SUMMARY
In summary, XBJ protects cardiac function partially by easing the
cytokine storm during systemic infection. Paeoniﬂorin and
Hydroxysafﬂor yellow A are key compounds in XBJ which exert
major functions of XBJ in managing septic shock. Like XBJ, they
protected cardiac function in septic shock. NF-κB, TNF-α, and
CXCL2 signaling are potential targets of XBJ and C0127s in
infection-induced cardiac dysfunction. This work indicated XBJ
may attenuate cytokine storm to protect the cardiac function of
septic shock and COVID-19 patients.
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